2 months ago
MEDP
AnalystsCharles RhyeeCharles Rhyee's Stock Forecasts
AnalystsCharles Rhyee
Analyst Ranking
Bottom 5%
#5053 out of 5266 analysts
Average Return
-7.23%
Win Rate
44%30 out of 68
Risk vs Reward
Poor
Good
Charles Rhyee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Talkspace IncTALK | +269.10% | $0.85 | $3.13 | 2023-05-02 - 2024-05-02 | Buy |
Teladoc Health IncTDOC | +141.52% | $95.97 | $231.79 | 2020-01-12 - 2021-01-13 | Buy |
Cardinal Health IncCAH | +69.09% | $122.53 | $207.19 | 2025-01-07 - 2026-01-07 | Strong Buy |
Cencora IncCOR | +45.06% | $159.03 | $230.69 | 2023-02-09 - 2024-02-09 | Buy |
Cencora IncCOR | +34.66% | $166.89 | $224.74 | 2023-05-02 - 2024-05-02 | Buy |
Charles Rhyee Analyst Color
Get additional color on Charles Rhyee's coverage of popular stocks
Charles Rhyee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Option Care Health IncOPCH | 3 | Hold | $23.00 | +14.83% | Maintains | 2 days ago |
Cardinal Health IncCAH | 4 | Strong Buy | $255.00 | +30.61% | Maintains | 2 days ago |
Fortrea Holdings IncFTRE | 5 | Strong Buy | $15.00 | +23.15% | Upgrades | 2 months ago |
Iqvia Holdings IncIQV | 4 | Strong Buy | $213.00 | +35.01% | Upgrades | 2 months ago |
Veeva Systems IncVEEV | 5 | Strong Buy | $300.00 | +74.83% | Maintains | 2 months ago |
Teladoc Health IncTDOC | 7 | Hold | $6.00 | -7.12% | Maintains | 2 months ago |
Charles River Laboratories International IncCRL | 7 | Strong Buy | $235.00 | +41.75% | Maintains | 2 months ago |
Talkspace IncTALK | 3 | Strong Buy | $9.00 | +73.41% | Maintains | 2 months ago |
Icon PLCICLR | 7 | Strong Buy | $120.00 | +6.34% | Upgrades | 2 months ago |
Medpace Holdings IncMEDP | 7 | Hold | $419.00 | +0.35% | Upgrades | 2 months ago |
Cigna GroupCI | 2 | Strong Buy | $338.00 | +19.48% | Maintains | 3 months ago |
Mckesson CorpMCK | 4 | Strong Buy | $1,012.00 | +24.32% | Maintains | 3 months ago |
Medline IncMDLN | 1 | Strong Buy | $46.00 | +2.79% | Initiates Coverage On | 4 months ago |
Goodrx Holdings IncGDRX | 8 | Strong Buy | $6.00 | +135.29% | Maintains | 6 months ago |
Cencora IncCOR | 14 | Strong Buy | $400.00 | +31.58% | Maintains | 6 months ago |
Cvs Health CorpCVS | 1 | Strong Buy | $100.00 | +21.82% | Maintains | 6 months ago |
R1 Rcm IncRCM | 1 | Hold | $14.30 | N/A | Downgrades | 2 years ago |
Veradigm IncMDRX | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
American Well CorpAMWL | 3 | Hold | $2.50 | N/A | Downgrades | 3 years ago |
Cue Health IncHLTHQ | 2 | Buy | $7.00 | N/A | Maintains | 3 years ago |
Science 37 Holdings IncSNCE | 2 | Buy | $60.00 | N/A | Maintains | 3 years ago |
Owlet IncOWLT | 2 | Buy | $56.00 | N/A | Maintains | 4 years ago |
Dariohealth CorpDRIO | 3 | Buy | $280.00 | N/A | Maintains | 4 years ago |
Evolent Health IncEVH | 1 | Buy | $50.00 | N/A | Maintains | 4 years ago |
Pear Therapeutics IncPEARQ | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Better Therapeutics IncBTTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Ontrak IncOTRKQ | 1 | Buy | $3,240.00 | N/A | Initiates Coverage On | 6 years ago |
Cerner CorpCERN | 1 | Buy | $79.00 | N/A | Upgrades | 6 years ago |
Premier IncPINC | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 8 years ago |
Heliogen IncHLGN | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Webmd Health CorpWBMD | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Castlight Health IncCSLT | 1 | Hold | $4.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.